Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2504

Dec 1, 2016

To fix its failing veteran healthcare system, the US Dept. of Veteran Affairs looks to AI

Posted by in categories: biotech/medical, government, health, robotics/AI

AI (someday once things are more secured) is going to drastically reduce our cost of government. At least the VA believes AI is going to make them better at treating folks; my guess it’s a mix of cost saving potential via automation and improving diagnosis.


Flow Health and the VA are building a medical knowledge graph with deep learning to inform medical decision-making and train AI to personalize care plans.

Read more

Dec 1, 2016

Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice

Posted by in category: biotech/medical

Osteoarthritis and senescent cells the connection becomes a little clearer!


Another step closer to the link between senescent cells and Osteoarthritis. Here we see mice receiving transplanted senescent cells which induce a disease state similar to Osteoarthritis. Yet further confirmation that the SENS approach to removing senescent cells is beneficial.

“Osteoarthritis (OA) is the leading form of arthritis in the elderly, causing pain, disability, and immobility. OA has been associated with accumulation of senescent cells in or near joints. However, evidence for a causal link between OA and cellular senescence is lacking. Here, we present a novel senescent cell transplantation model involving injection of small numbers of senescent or nonsenescent cells from the ear cartilage of luciferase-expressing mice into the knee joint area of wild-type mice. By using bioluminescence and 18FDG PET imaging, we could track the injected cells in vivo for more than 10 days. Transplanting senescent cells into the knee region caused leg pain, impaired mobility, and radiographic and histological changes suggestive of OA. Transplanting nonsenescent cells had less of these effects. Thus, senescent cells can induce an OA-like state and targeting senescent cells could be a promising strategy for treating OA.”

Continue reading “Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice” »

Dec 1, 2016

Building “genetic circuits” in cells could kill tumors

Posted by in categories: bioengineering, biotech/medical, genetics

More on the cell circuited technology that will deprive cancer cells of oxygen.


Imagine having cells in your body that can actively repel cancer in a way that makes it theoretically impossible for you to suffer from it.

Researchers at the U.K.’s University of Southampton…have engineered cells with a so-called “built-in genetic circuit” capable of producing a molecule for inhibiting the ability of tumors to grow and survive in the body.

Continue reading “Building ‘genetic circuits’ in cells could kill tumors” »

Dec 1, 2016

Neuroscience Is a Tool of War

Posted by in categories: biotech/medical, computing, drones, government, military, neuroscience

What could once only be imagined in science fiction is now increasingly coming to fruition: Drones can be flown by human brains’ thoughts. Pharmaceuticals can help soldiers forget traumatic experiences or produce feelings of trust to encourage confession in interrogation. DARPA-funded research is working on everything from implanting brain chips to “neural dust” in an effort to alleviate the effects of traumatic experience in war. Invisible microwave beams produced by military contractors and tested on U.S. prisoners can produce the sensation of burning at a distance.

What all these techniques and technologies have in common is that they’re recent neuroscientific breakthroughs propelled by military research within a broader context of rapid neuroscientific development, driven by massive government-funded projects in both America and the European Union. Even while much about the brain remains mysterious, this research has contributed to the rapid and startling development of neuroscientific technology.

Continue reading “Neuroscience Is a Tool of War” »

Dec 1, 2016

Russia unveils CLONE DOGS that will work with Putin’s Special Forces

Posted by in categories: biotech/medical, genetics

The CLONED dogs of war: Russia unveils genetically-enhanced canines which will work with Putin’s Special Forces and were created by scientist attempting to restore woolly mammoths

  • The three Belgian Malinois were cloned by a South Korean professor
  • He also aims to one day restore extinct woolly mammoths to Siberia
  • Dr Hwang Woo Suk gifted the dogs — each valued at $100,000 — to police
  • The will be used in Yakutia, the coldest inhabited region in the world

By Will Stewart In Moscow for MailOnline

Continue reading “Russia unveils CLONE DOGS that will work with Putin’s Special Forces” »

Nov 30, 2016

Drugs to Extend Life — Nathaniel David, CEO of Unity Biotechnology

Posted by in categories: biotech/medical, life extension

Nathaniel David from Unity Biotech giving a talk about the potential of Senolytics and how science can break the natural limit to lifespan. David is the CEO of Unity Biotechnology a company taking SENS based Senolytic drugs into human clinical trials in the next year or so. Very exciting as this is the first true rejuvenation biotechnology therapy to be deployed in humans.


Unity is leading the way for the first rejuvenation technologies in the #sens model. Here we have Nathaniel David from Unity talking about the potential of Senolytics and increased lifespans.

Continue reading “Drugs to Extend Life — Nathaniel David, CEO of Unity Biotechnology” »

Nov 30, 2016

Mitochondrial Repair Project

Posted by in categories: biotech/medical, genetics, life extension

A look back at one of the milestones for SRF and the first successful fundraiser on Lifespan.io for MitoSENS.


We need your support at this critical juncture of the MitoSENS project. The MitoSENS team has already demonstrated the rescue of cells containing mitochondrial mutations, and has recently generated highly promising preliminary data showing the rescue of the complete loss of a mitochondrial gene. Our next steps will focus on improving the effectiveness of the targeting system, so that we can repeat our success with one mitochondrial gene to all thirteen. We will then transition this work into animal models of mitochondrial dysfunction. This would be a crucial step in what may be the development of an eventual cure for aging and aging related diseases.

Continue reading “Mitochondrial Repair Project” »

Nov 29, 2016

Depression Treatment

Posted by in categories: biotech/medical, neuroscience, wearables

https://youtube.com/watch?v=melzXkH8KPY

The Happy Headband. Take my money.


The Fisher Wallace Stimulator® is a wearable neurostimulation device that is cleared by the FDA to treat depression and anxiety. During each 20-minute treatment session, the device gently stimulates the brain to produce serotonin and other neurochemicals that reduce depression and anxiety (and support healthy mood and sleep). The device has been proven to be safe and effective in multiple published studies conducted at top institutions such as Mount Sinai Beth Israel Hospital.

Continue reading “Depression Treatment” »

Nov 29, 2016

Vote for your scientific breakthrough of the year!

Posted by in categories: biotech/medical, life extension

Vote for senolytics and help get aging research into public view.


Please VOTE NOW for senescent cell removal (The purge that refreshes) and help make aging research the science breakthrough of the year and get rejuvenation biotechnology into the public eye.

#aging #sens

Continue reading “Vote for your scientific breakthrough of the year!” »

Nov 29, 2016

Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

Posted by in category: biotech/medical

More results concerning Liz Parrish, this is the important part:

No negative effects have been reported, and there are no visible detrimental effects in blood analysis thus far; providing tentative evidence of safety in the first human test of BioViva’s dual gene therapy strategy.


Biomarker analysis and MRI imaging data from the past year have revealed beneficial metabolic changes and muscle improvement in Elizabeth Parrish, CEO of BioViva USA Inc. and recipient of BioViva’s experimental dual gene therapy in September 2015.

Continue reading “Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition” »